The Practical Dermatology Podcast

In this first installment of a two-part episode of The Practical Dermatology Podcast, Brooke Jackson, MD, founder and owner of Skin Wellness Dermatology Associates in Durham, NC, and a dermatologic surgeon and dermatologist, speaks about hair loss in patients with diverse skin tones, the timing of hair washing, and how to work with patients with different types of hair. 

 A panel discussion led by Neal Bhatia, MD, reveals the efforts--large and small--being made by dermatologists Laura Ferris, MD, Vishal Patel, MD, and Todd Schlesinger, MD, to combat skin cancer in their clinics and in their communities.

Dr. Estee Williams, an assistant clinical professor of dermatology at Mount Sinai Medical Center in New York City and an official spokesperson for the National Rosacea Society, explains why treating rosacea is a marathon, not a sprint, in this episode of Practical Dermatology: The Podcast.

Physician burnout remains a conversation, and the pandemic dramatically changed the landscape for dermatologists—for better and for worse. Omaha, NE-based Joel Schlessinger, MD, who serves as Chief Cosmetic Surgery Editor of Practical Dermatology® speaks with Las Vegas-based dermatologist H.L. Greenberg, MD, about the importance of physicians finding “multiple sources of happiness” in this episode of Practical Dermatology: The Podcast.

Black, Hispanic, Asian, and other people of color with plaque psoriasis and psoriatic arthritis often face delayed diagnosis, misdiagnosis, and limited access to testing, treatment, and care. Determi-Nation, a new initiative sponsored by Janssen Pharmaceuticals, aims to change this. Patient advocate Alisha Bridges, Grace Wright, MD, PhD, president of the Association of Women in Rheumatology in New York City, and Naureen Kabani, MD, a rheumatologist with SUNY Downstate in Brooklyn, New York, discuss how this new program will help close gaps and improve access to care for people of color with psoriatic disease.

There’s no paucity of studies for biologic therapies used to treat psoriatic disease, but the number of head-to-head trials comparing these agents is limited. Enter network meta-analysis, a statistical methodology that has emerged over the past few years to compare medication. Philip Mease, MD, a clinical professor at the University of Washington School of Medicine and director of rheumatology research at the Swedish Medical Center in Seattle, and Dr. Wolf-Henning Boehncke, chair of the division of dermatology and venereology at Geneva University Hospitals, Switzerland, and full professor at the Department of Pathology and Immunology at Geneva University, discuss the use of network meta-analyses and potential pitfalls in choosing biologic therapies for patients with psoriasis and psoriatic arthritis in this episode of Practical Dermatology: The Podcast.

In 2014, the American Society for Laser Medicine and Surgery started its New Beginnings initiative. Initially launched to benefit cancer survivors, ASLMS physicians volunteered to remove radiation tattoos pro bono. Recently, the ASLMS, under the leadership of its president Paul Friedman, MD, expanded the philanthropic campaign to create the New Beginnings Branding Tattoo Removal Program and partnered with the National Trafficking Sheltered Alliance to connect board-certified physicians with sex trafficking survivors for pro bono laser removal of branding tattoos. Alisha Merlo, the Executive Director of Professional Relations at Colorescience, and dermatologists Dr. Friedman, Dr. Emily Guo, and Dr. Elizabeth Kream discuss the impact of this work and their goals for the future of this initiative. Listen now.

The Digital Medicine Society (DiME) is a global nonprofit dedicated to advancing the ethical, effective, equitable, and safe use of digital medicine to redefine health care and improve lives. DiME recently released a new set of resources, available at www.dimesociety.org/access-resources/, to advance the use of digitally measured nocturnal scratch as a meaningful endpoint for atopic dermatitis. These tools, along with DiMe’s previous work to support digital clinical measures, lay the groundwork for future use of the measure in clinical research, technology development, and reimbursement decisions—thereby furthering dermatology research and improving the lives of AD patients and caregivers. Jennifer Goldsack, DiME CEO, and Lucy Cesnakova, a program lead at DiMe, discuss their work and its impact on the field. Listen now.

Discover the Practical Dermatology podcast, taking you into the world of dermatology care with in-depth conversations with physicians, medical aesthetics industry, and other healthcare experts.